Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
US Army
Covington
Daiichi Sankyo
Cipla
Teva
McKinsey
Johnson and Johnson
Mallinckrodt

Generated: April 25, 2018

DrugPatentWatch Database Preview

ASELLACRIN 10 Drug Profile

« Back to Dashboard

When do Asellacrin 10 patents expire, and when can generic versions of Asellacrin 10 launch?

Asellacrin 10 is a drug marketed by Serono and is included in one NDA.

The generic ingredient in ASELLACRIN 10 is somatropin. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the somatropin profile page.
Summary for ASELLACRIN 10
Drug patent expirations by year for ASELLACRIN 10

US Patents and Regulatory Information for ASELLACRIN 10

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Serono ASELLACRIN 10 somatropin INJECTABLE;INJECTION 017726-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Harvard Business School
Colorcon
Fuji
Farmers Insurance
US Department of Justice
Citi
Argus Health
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.